These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3135778)

  • 1. Leakage of immobilized IgG from therapeutic immunoadsorbents.
    Sato H; Kidaka T; Hori M
    Appl Biochem Biotechnol; 1987 Aug; 15(2):145-58. PubMed ID: 3135778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterilization of therapeutic immunoadsorbents by ionizing radiation.
    Sato H; Kidaka T; Hori M
    Int J Artif Organs; 1986 Mar; 9(2):131-6. PubMed ID: 3084388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Properties of immunoadsorbents prepared by antigen coupling to glutaraldehydeactivated polyacrylamide gel, BrCN-activated Sepharose and by copolymerization of antigens by glutaraldehyde].
    Komissarenko SV; Avrameas S
    Ukr Biokhim Zh (1978); 1978; 50(4):500-11. PubMed ID: 98883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical studies of the non-specific interactions of cyanogen bromide-activated macroporous agarose-based immunoadsorbents.
    Kennedy JF; Barnes JA
    J Chromatogr; 1983 Dec; 281():83-93. PubMed ID: 6668343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compared stability of Sepharose-based immunoadsorbents prepared by various activation methods.
    Ubrich N; Hubert P; Regnault V; Dellacherie E; Rivat C
    J Chromatogr; 1992 Dec; 584(1):17-22. PubMed ID: 1487514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies released from immunoadsorbents: effect of support, activation and elution conditions.
    Ubrich N; Rivat C
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Jan; 24(1):65-75. PubMed ID: 8714720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sterilization of therapeutic immunoadsorbents with aqueous propylene oxide solution.
    Sato H; Kidaka T; Hori M
    Int J Artif Organs; 1985 Mar; 8(2):109-14. PubMed ID: 3921468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological safety assessments of anti-IgE antibody which is detached from therapeutic immunoadsorbents for removing IgE.
    Sato H; Kidaka T
    J Biomed Mater Res; 1989 Nov; 23(11):1343-54. PubMed ID: 2606926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insoluble human plasma protein immunoadsorbents. Large-scale production and storage.
    Nerenberg ST; Prasad R; Biskup N; Pedersen L
    Clin Chim Acta; 1977 Feb; 74(3):237-45. PubMed ID: 12895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microporous microparticles designed as stable immunoadsorbents.
    Ubrich N; Rivat C; Vigneron C; Maincent P
    Biotechnol Bioeng; 1998 Jun; 58(6):581-6. PubMed ID: 10099295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme and radioimmunoassays for specific murine IgE and IgG with different solid-phase immunosorbents.
    Giallongo A; Kochoumian L; King TP
    J Immunol Methods; 1982 Aug; 52(3):379-93. PubMed ID: 6752278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of alginate ester films on solid supports in the preparation of water-insoluble immunoadsorbents for purification of antigens.
    Kennedy JF; Barnes JA; Barker SA
    Eur J Biochem; 1983 Jul; 133(3):697-705. PubMed ID: 6861751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonimmunospecific protein-protein interactions of IgG: studies of the binding of IgG to IgG immunoadsorbents.
    Nardella FA; Mannik M
    J Immunol; 1978 Mar; 120(3):739-44. PubMed ID: 75921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of F(ab')2 antibody fragments in the synthesis of immunoadsorbents for preparing monospecific antigen.
    Kennedy JF; Barnes JA
    J Chromatogr; 1981 Jul; 212(2):179-86. PubMed ID: 7263797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of parameters involved in specific immunoadsorption of apolipoprotein B.
    Regnault V; Rivat C; Marcillier P; Pfister M; Michaely JP; Didelon J; Schooneman F; Stoltz JF; Siadat M
    Int J Artif Organs; 1990 Nov; 13(11):760-7. PubMed ID: 2128486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific removal of IgE by therapeutic immunoadsorption system.
    Sato H; Watanabe K; Azuma J; Kidaka T; Hori M
    J Immunol Methods; 1989 Mar; 118(2):161-8. PubMed ID: 2647856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optimization of methods of immobilization of anti-immunoglobulins. Equilibrium parameters of the interaction of immobilized antibodies with an antigen].
    Guzov VM; Rodionov MA; Golubovich VP; But'kova LS; Chashchin VL
    Biokhimiia; 1988 Feb; 53(2):238-50. PubMed ID: 3285896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosorbent consisting of DNA immobilized on oxirane-activated sepharose.
    Nagasawa J; Suehiro T; Yamauchi A
    J Appl Biochem; 1985 Dec; 7(6):430-7. PubMed ID: 3831008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody immobilization onto glow discharge treated polymers.
    Safranj A; Kiaei D; Hoffman AS
    Biotechnol Prog; 1991; 7(2):173-7. PubMed ID: 1367512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversed immunosorbents: a simple method for specific antibody immobilization.
    Levy DE; Eveleigh JW
    J Immunol Methods; 1978; 22(1-2):131-42. PubMed ID: 670722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.